Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125826361 | 12582636 | 1 | I | 20160718 | 20160722 | 20160722 | EXP | US-ROCHE-1797202 | ROCHE | KLUTE K, BROUWER J, JHAWER M, SACHS H, GANGADIN A, OCEAN A, POPA E, DAI T, WU G, CHRISTOS P AND SHAH M. CHEMOTHERAPY DOSE INTENSITY PREDICTED BY BASELINE NUTRITION ASSESSMENT IN GASTROINTESTINAL MALIGNANCIES: A MULTICENTRE ANALYSIS. EUROPEAN JOURNAL OF CANCER 2016;63:189-200. | 0.00 | Y | 0.00000 | 20160722 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125826361 | 12582636 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
| 125826361 | 12582636 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | ||||||||||
| 125826361 | 12582636 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 5 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 6 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 7 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 8 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 9 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 10 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 11 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 12 | SS | NAB-PACLITAXEL | PACLITAXEL | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 13 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 14 | SS | MITOMYCIN. | MITOMYCIN | 1 | Unknown | U | 0 | ||||||||||
| 125826361 | 12582636 | 15 | SS | SORAFENIB | SORAFENIB | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125826361 | 12582636 | 1 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 2 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 3 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 4 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 5 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 6 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 7 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 8 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 9 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 10 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 11 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 12 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 13 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 14 | Gastrointestinal carcinoma |
| 125826361 | 12582636 | 15 | Gastrointestinal carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125826361 | 12582636 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125826361 | 12582636 | Asthenia | |
| 125826361 | 12582636 | Diarrhoea | |
| 125826361 | 12582636 | Failure to thrive | |
| 125826361 | 12582636 | Fatigue | |
| 125826361 | 12582636 | Haematotoxicity | |
| 125826361 | 12582636 | Neutropenia | |
| 125826361 | 12582636 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |